InvestorsHub Logo
Followers 0
Posts 3727
Boards Moderated 0
Alias Born 10/23/2017

Re: None

Tuesday, 09/14/2021 8:58:21 AM

Tuesday, September 14, 2021 8:58:21 AM

Post# of 694218
FeMike's conversation with DI tells me two things. One, sounds like peer-review is ongoing. I can't imagine an expert in GBM not expediting review and comment if data is as good as I hope. They will want to get this news out so patients can benefit. Obviously, can't be expedient at the expense of critical review and to diffuse naysayers. Two, 2021 may be out of the question for release of Topline data and Journal. Who knows though as we do not know when they got the data to experts for review.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News